Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Biora Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 25 | 30 | +5 |
| Shares | 11.9M | 11.9M | −33.7K (−0.3%) |
| Value | $25.9M | $16.1M | −$9.83M (−38.0%) |
New holders (8)
Institutions that held Biora Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 50,849 | $68.6K | 0.00% |
| Virtu Financial LLC | 19,763 | $27.0K | 0.00% |
| Engineers Gate Manager LP | 15,085 | $20.4K | 0.00% |
| UBS Group AG | 6,146 | $8.30K | 0.00% |
| TD Waterhouse Canada Inc. | 1,120 | $1.58K | 0.00% |
| Qube Research & Technologies Ltd | 100 | $135 | 0.00% |
| FMR LLC | 80 | $108 | 0.00% |
| Bank of America Corp | 14 | $18 | 0.00% |
Sold out (3)
Institutions that held Biora Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Sabby Management, LLC | 376,557 | $817.1K |
| Group One Trading, L.P. | 4,699 | $10.2K |
| Northwestern Mutual Wealth Management Co | 20 | $43 |